Effects of blockade of fast and slow inward current channels on ventricular fibrillation in the pig heart

Heart

Volumn 76, Issue 6, 1996, Pages 513-519

  Stewart, Adrian J ^b   Allen, J Desmond ^b   Devine, Adrian B ^b   Adgey, A A Jennifer ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b NONE

Author keywords

antiarrhythmics; ventricular fibrillation

Indexed keywords

CALCIUM CHANNEL; DISOPYRAMIDE; FLECAINIDE; LIDOCAINE; MEXILETINE; SODIUM CHANNEL; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; ELECTROCARDIOGRAM; FEMALE; HEART VENTRICLE FIBRILLATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0030473694     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.6.513     Document Type: Article

References (43)

1. Janse MJ, van Capelle FJL, Morsink H, Kléber AG, Wilms-Schopman F, Cardinal R, et al. Flow of "injury" current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts. Circ Res 1980;47: 151-65.
2. Pogwizd SM, Corr PB. Mechanisms underlying ventricular tachycardia and fibrillation in the ischemic heart: relation to nonlinear dynamics. Ann NY Acad Sci 1990;591: 278-300.
3. Ideker RE, Klein GJ, Harrison L, Smith WM, Kasell J, Reimer KA, et al. The transition to ventricular fibrillation induced by reperfusion after acute ischemia in the dog: a period of organised epicardial activation. Circulation 1981;63:1371-9.
4. Nygards M, Hulting J. Recognition of ventricular fibrillation utilizing the power spectrum of the ECG. IEEE Computers in Cardiology 1977;4:393-7.
5. Goldberger AL, Bhargava V, West BJ, Mandell AJ. Some observations on the question: is ventricular fibrillation "chaos"? Physica 1986;19D:282-9.
6. Carlisle EJF, Allen JD, Kernohan WG, Anderson J, Adgey AAJ. Fourier analysis of ventricular fibrillation of varied aetiology. Eur Heart J 1990;11:173-81.
7. Stewart AJ, Allen JD, Adgey AAJ. Frequency analysis of ventricular fibrillation and resuscitation success. Quart J Med 1992;85:761-9.
8. Clayton RH, Murray A, Campbell RWF. Changes in the surface electrocardiogram during the onset of spontaneous ventricular fibrillation in man. Eur Heart J 1994;15:184-8.
9. Clayton RH, Murray A, Campbell RWF. Analysis of the body surface ECG measured in independent leads during ventricular fibrillation in humans. PACE 1995;18: 1876-81.
10. Task Force of the Working Group on Arrhythmias. The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991;84:1831-51.
11. Davis J, Matsubara T, Scheinman MM, Katzung B, Hondeghem LH. Use-dependent effects of lidocaine on conduction in canine myocardium: application of the modulated receptor hypothesis in vivo. Circulation 1986; 74:205-14.
12. Pallandi RT, Campbell TJ. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs. Cardiovasc Res 1988;22:171-8.
13. Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24:129-47.
14. Grant AO, Wendt DJ. Blockade of ion channels by antiarrhythmic drugs. J Cardiovasc Electrophysiol 1991;2:suppl S153-S68.
15. Merillat JC, Lakatta EG, Hano O, Guarnieri T. Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation. Circ Res 1990;67: 1115-23.
16. Kojima S, Wikman-Coffelt J, Wu ST, Parmley WW. Nature of [Ca++] transients during ventricular fibrillation and quinidine treatment in perfused rat hearts. Am J Physiol 1994;266:H1473-84.
17. Koretsune Y, Marban E. Cell calcium in the pathophysiology of ventricular fibrillation and in the pathogenesis of postarrhythmic contractile dysfunction. Circulation 1989; 80:369-79.
18. Vincent JL, Goldstein J, Dufaye P, Domb M. Electromechanical dissociation after ventricular fibrillation: prevention with calcium-entry blockers. J Cardiovasc Pharmacol 1984;6:1124-31.
19. Martin G, Cosin J, Such M, Hernandez A, Llamas P. Relation between power spectrum time course during ventricular fibrillation and electromechanical dissociation. Effects of coronary perfusion and nifedipine. Eur Heart J 1986;7:560-9.
20. Muller CA, Opie LH, Hamm CW, Peisach M, Pineda CA, Thandroyen FT. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Circulation 1988;78:227-32.
21. Jenkins MG, Johnson TA, Engle C, Gettes LS. Metabolic protection by verapamil during graded coronary flow reduction independent of effect on baseline systolic function. Circulation 1989;80:1870-7.
22. Brown CG, Dzwonczyk R, Werman HA, Hamlin RL. Estimating the duration of ventricular fibrillation. Ann Emerg Med 1989;18:1181-5.
23. Pedersen LE, Hermansen K, Olesen HP, Rasmussen SN. The pharmacokinetics and protein binding of disopyramide in pigs. Acta Pharmacol Toxicol 1986;58:282-8.
24. Vogt B, Martin C, Meesmann W. Prophylactic lidocaine: concentrations in plasma and myocardial tissue and antifibrillatoric efficacy during early ischemia in dogs and pigs. J Cardiovasc Pharmacol 1988;12:571-8.
25. Verdouw PD, Deckers JW, Conard GJ. Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart. J Cardiovasc Pharmacol 1979,1: 473-86.
26. Stearns SD, Hush DR. Digital signal analysis. Englewood Cliffs, NJ: Prentice-Hall International, 1990.
27. Kaplan DT, Cohen RJ. Is fibrillation chaos? Circ Res 1990; 67:886-92.
28. Rosen MR, Hoffman BF, Wit AL. Electrophysiology and pharmacology of cardiac arrhythmias. V. Cardiac antiarrhythmic effects of lidocaine. Am Heart J 1975;89: 526-36.
29. Allen JD, James RGG, Kelly JG, Shanks RG, Zaidi SA. Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias. Postgrad Med J 1977;53 (suppl 1): 35-45.
30. Echt DS, Black JN, Barbey JT, Coxe DR, Cato E. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs: sodium channel block and action potential prolongation. Circulation 1989;79: 1106-17.
31. Echt DS, Mason JW. Management of serious cardiac arrhythmias with drugs. In: Conti CR, ed. Cardiovascular Clinics 14/3: Cardiac drug therapy. Philadelphia: FA Davis Company, 1984:191-209.
32. Marshall RJ, Parratt JR. The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs. Br J Pharmacol 1979;66:241-50.
33. Ca in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. Am J Physiol 1989;256:C549-59.
34. Carlisle EJF, Allen JD, Kernohan WG, Leahey WA, Adgey AAJ. Pharmacological analysis of established ventricular fibrillation. Br J Pharmacol 1990;100:530-4.
35. Hirata Y, Kodama I, Iwamura N, Shimizu T, Toyama J, Yamada K. Effects of verapamil on canine Purkinje fibres and ventricular muscle fibres with particular reference to the alternation of action potential duration after a sudden increase in driving rate. Cardiovasc Res 1979;13:1-8.
36. Elharrar V, Gaum W, Zipes D. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Am J Cardiol 1977;39:544-9.
37. Fondacaro JD, Han J, Yoon MS. Effects of verapamil on ventricular rhythm during acute coronary occlusion. Am Heart J 1978;96:81-6.
38. Gulker H, Thale J, Haverkamp W, Hindricks G, Holtschule A, Mann B, et al. Time course of ventricular arrhythmias, fibrillation thresholds and epicardial conduction delays following acute coronary artery occlusion and release - its modification by verapamil. In: Fleckenstein A, Laragh JH, eds. Hypertension - the next decade. Edinburgh: Churchill-Livingstone, 1987; 237-44.
39. +, pH and local activation in the pig. Circulation 1986;73:837-46.
40. Sherman LG, Liang CS, Boden WE, Hood WB Jr. The effect of verapamil on mechanical performance of acutely ischemic and reperfused myocardium in the conscious dog. Circ Res 1981;48:224-32.
41. Auffermann W, Wagner S, Wu S, Buser P, Parmley WW, Wikman-Coffelt J. Calcium inhibition of glycolysis contributes to ischaemic injury. Cardiovasc Res 1990;24: 510-20.
42. Dahl G, Isenberg G. Decoupling of heart muscle cells: correlation with increased cytoplasmic calcium activity and with changes of nexus ultrastructure. J Memb Biol 1980; 53:63-75.
43. Schräder R, Brooks M, Echt DS. Effects of verapamil and Bay K8644 on defibrillation energy requirements in dogs. J Cardiovasc Pharmacol 1992;19:839-50.